Commercial bias in medicine occurs when financial interests—from pharmaceutical firms, device makers, or industry-funded research—shape clinical evidence, prescribing habits, and treatment guidelines. This influence can skew data, prioritize profitable drugs over cheaper alternatives, and amplify marketing over patient outcomes. Ultimately, shareholders and industry executives benefit most, while patients face inflated costs and potentially suboptimal care. Understanding this bias is crucial for evidence-based decision-making.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends